CoChat

Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder

Open access
Gama, Clarissa Severino, Andreazza, Ana Cristina, Kunz, Maurício, Berk, Michael, Belmonte-de-Abreu, Paulo Silva, Kapczinski, Flavio · 2007 · Neuroscience Letters
Cited by 153

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

There is evidence that major psychiatric discords such as schizophrenia (SZ) and bipolar disorder (BD) are associated with dysregulation of synaptic plasticity with downstream alterations of neurotrophins. Brain-derived neurotrophic factor (BDNF) is the most widely distributed neurotrophin in the central nervous system (CNS), and performs many biological functions such as promoting the survival, differentiation, and plasticity of neurons. Variants in the BDNF gene increase the risk of SZ and bipolar disorder. Chronic administration of drugs used to treat SZ and BD, such as lithium, valproate, quetiapine, clozapine, and olanzapine, increases BDNF expression in rat brain. To examine serum BDNF, three groups of chronically medicated DSM-IV SZ patients, on treatment with clozapine (n=27), typical (n=14), and other atypical antipsychotics (n=19), 30 euthymic BD patients, and 26 healthy control had 5 ml blood samples collected by venipuncture. Serum BDNF levels were significantly higher in SZ patients (p<0.001) when compared to either controls or euthymic BD patients. Increased BDNF in SZ patients might be related to the course of illness or to treatment variables. Prospective studies are warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neulet.2007.04.001

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 26

  1. Azevedo, 1999, Using consensus OPCRIT diagnoses – an efficient procedure for best-estimate lifetime diagnoses, Br. J. Psychiatry, 175, 154, 10.1192/bjp.175.2.154 · DOI · Paper page
  2. Bai, 2003, Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs, J. Neurosci. Res., 71, 127, 10.1002/jnr.10440 · DOI · Paper page
  3. Chen, 2006, Association between the brain-derived neurotrophic factor (BDNF) gene and schizophrenia in the Chinese population, Neurosci. Lett., 397, 285, 10.1016/j.neulet.2005.12.033 · DOI
  4. Coyle, 2003, Finding the intracellular signaling pathways affected by mood disorder treatments, Neuron., 38, 157, 10.1016/S0896-6273(03)00195-8 · DOI · Paper page
  5. Craddock, 1996, Concurrent validity of the OPCRIT diagnostic system – comparison of OPCRIT diagnoses with consensus best-estimate lifetime diagnoses, Br. J. Psychiatry, 169, 58, 10.1192/bjp.169.1.58 · DOI · Paper page
  6. Cunha, 2006, Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes, Neurosci. Lett., 398, 215, 10.1016/j.neulet.2005.12.085 · DOI · Paper page
  7. Frey, 2006, Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania, Life Sci., 79, 281, 10.1016/j.lfs.2006.01.002 · DOI · Paper page
  8. Fukumoto, 2001, Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain, Psychopharmacology (Berl), 158, 100, 10.1007/s002130100871 · DOI · Paper page
  9. Gama, 2006, Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine, Prog. Neuropsychopharmacol. Biol. Psychiatry, 30, 512, 10.1016/j.pnpbp.2005.11.009 · DOI · Paper page
  10. Grillo, 2007, Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics, J. Psychiatr. Res., 41, 31, 10.1016/j.jpsychires.2006.01.005 · DOI · Paper page
  11. Hamilton, 1960, A rating scale for depression, J. Neurol. Neurosurg. Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
  12. Jockers-Scherubl, 2004, Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse, Neurosci. Lett., 371, 79, 10.1016/j.neulet.2004.08.045 · DOI
  13. Jonsson, 2006, Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study, Prog. Neuropsychopharmacol. Biol. Psychiatry, 30, 924, 10.1016/j.pnpbp.2006.02.008 · DOI
  14. Lieberman, 1999, Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia, J. Clin. Psychiatry, 60, 9
  15. Lohoff, 2005, Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder, Am. J. Med. Genet. B Neuropsychiatr. Genet., 139, 51, 10.1002/ajmg.b.30215 · DOI · Paper page
  16. Machado-Vieira, 2007, Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode, Biol. Psychiatry, 61, 142, 10.1016/j.biopsych.2006.03.070 · DOI · Paper page
  17. Mahadik, 2006, Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia, Int. Rev. Psychiatry, 18, 119, 10.1080/09540260600581993 · DOI · Paper page
  18. Neves-Pereira, 2002, The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study, Am. J. Hum. Genet., 71, 651, 10.1086/342288 · DOI · Paper page
  19. Park, 2006, Effects of quetiapine on the brain-derived neurotrophic factor expression in the hippocampus and neocortex of rats, Neurosci. Lett., 402, 25, 10.1016/j.neulet.2006.03.028 · DOI
  20. Palomino, 2006, Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients, Schizophr. Res., 86, 321, 10.1016/j.schres.2006.05.028 · DOI · Paper page
  21. Qian, 2007, Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis, Biochem. Biophys. Res. Commun., 353, 738, 10.1016/j.bbrc.2006.12.121 · DOI
  22. Rybakowski, 2003, Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients, Bipolar Disord., 5, 468, 10.1046/j.1399-5618.2003.00071.x · DOI · Paper page
  23. Rybakowski, 2006, Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene, Psychiatry Clin. Neurosci., 60, 70, 10.1111/j.1440-1819.2006.01462.x · DOI · Paper page
  24. Strakowski, 2005, Abnormal FMRI brain activation in euthymic bipolar disorder patients during a counting Stroop interference task, Am. J. Psychiatry, 162, 1697, 10.1176/appi.ajp.162.9.1697 · DOI · Paper page
  25. Tan, 2005, Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics, Neurosci. Lett., 382, 27, 10.1016/j.neulet.2005.02.054 · DOI
  26. Tan, 2005, Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements, Schizophr. Res., 74, 263, 10.1016/j.schres.2004.08.004 · DOI

Cited by

See all 153

Metadata

Authors
Gama, C. S., Andreazza, A. C., Kunz, M., Berk, M., Belmonte-de-Abreu, P. S., & Kapczinski, F.
Venue
Neuroscience Letters
Publisher
Elsevier BV
Published
2007-06
Volume
420
Issue
1
Pages
45-48
ISSN
0304-3940 (ISSN-L)
OpenAlex
W2039636801
Cited by
153
References
6
FWCI
8.37
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.